The Aims of the Study Are to Translate the Index of Professional Governance (IPG 3.0) Into Italian and Validate It and to Assess the State of Professional Governance in an Italian Hospital (ISMETT)
Launched by THE MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES · Feb 3, 2025
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial aims to translate and validate a tool called the Index of Professional Governance (IPG 3.0) into Italian. The IPG 3.0 is designed to measure how well healthcare professionals work together to direct and improve their work environment and patient care. By understanding the level of professional governance in an Italian hospital (ISMETT), the study hopes to identify areas for improvement and empower staff to take part in decision-making processes that enhance their work and the care they provide to patients.
To participate in this trial, individuals must have at least one year of professional experience and demonstrate adequate English language skills. Participants will complete a questionnaire that includes 50 questions about their roles in governance, helping researchers understand how decisions are made in their hospital. This study is important because it will help create a better working environment for healthcare professionals, which can lead to higher quality care for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1 year of professional seniority
- • possess adequate linguistic skills certified by passing an English test (prepared by the linguistic services of the promoting center).
About The Mediterranean Institute For Transplantation And Advanced Specialized Therapies
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT) is a leading clinical research organization dedicated to advancing the fields of transplantation and specialized medical therapies. Situated in a state-of-the-art facility in Palermo, Italy, ISMETT combines innovative research with cutting-edge clinical practices to enhance patient outcomes and develop novel therapeutic strategies. The institute is committed to fostering collaboration among multidisciplinary teams of experts and leveraging its robust infrastructure to conduct high-quality clinical trials. Through its focus on scientific excellence and patient-centered care, ISMETT aims to contribute significantly to the fields of organ transplantation and advanced therapies on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported